Calcium channel blocker toxicity

Pediatric Emergency Care

Volumn 25, Issue 8, 2009, Pages 532-541

  Arroyo, Anna Maria ^b   Kao, Louise W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium channel blocker; Glucagon; Insulin; Lipid emulsion; Poisoning

Indexed keywords

4 AMINOPYRIDINE; ACTIVATED CARBON; AMLODIPINE; AMRINONE; BICARBONATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FELODIPINE; GLUCAGON; INSULIN; ISRADIPINE; LIPID EMULSION; METARAMINOL; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; TERLIPRESSIN; VASOPRESSIN; VERAPAMIL;

ANAPHYLAXIS; AORTA BALLOON; BEZOAR; CARDIOVASCULAR SYMPTOM; CONTINUOUS INFUSION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INTOXICATION; DRUG MECHANISM; DRUG OVERDOSE; EXTRACORPOREAL CIRCULATION; EXTRAVASATION; FAT EMBOLISM; FIRST PASS EFFECT; HEART ATRIUM ARRHYTHMIA; HEART CONDUCTION; HEART PACING; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; INFECTION RISK; LOADING DRUG DOSE; LUNG EDEMA; MENTAL DISEASE; METABOLIC ACIDOSIS; MUSCLE CONTRACTION; NAUSEA; NONHUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PLASMAPHERESIS; PROTEIN BINDING; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SEPTIC SHOCK; SIDE EFFECT; SKIN NECROSIS; STOMACH LAVAGE; THROMBOPHLEBITIS; VASODILATATION; VOMITING;

ADULT; ASSISTED CIRCULATION; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHLORIDE; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHARCOAL; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ENEMA; EXTRACORPOREAL CIRCULATION; FAT EMULSIONS, INTRAVENOUS; FLUID THERAPY; GLUCAGON; HEART; HUMANS; HYPERGLYCEMIA; INFANT; MUSCLE, SMOOTH, VASCULAR; OVERDOSE; PLASMAPHERESIS; POISONING; PRACTICE GUIDELINES AS TOPIC;

EID: 69549119168     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181b0a504     Document Type: Review

References (55)

1. DRUGDEX® System[database online]. In: Thomson Healthcare, Greenwood Village, Colorado; 2008.
2. DeRoos F. Calcium channel blockers. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw-Hill; 2006:911-923.
3. Product Information: Sular (Nisoldipine) Extended Release Tablets For Oral Use. Atlanta, GA: Sclele Pharma, Inc; 2006.
4. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila). 2006;44(6-7):803-932.
5. Bronstein AC, Spyker DA, Scantelena LR, et al. 2006 annual report of the American association of poison control centers: National Poison Data Systems (NPDS). Clin Toxicol. 2007;45:815-917.
6. CORE Report: Summary log for human exposure cases by generic categories and subcategories. 2007. Accessed at https://www.npds.us/reports/reports.aspx on May 8, 2008.
7. Maiteh M, Daoud AS. Myoclonic seizure following intravenous verapamil injection: case report and review of the literature. Ann Trop Paediatr. 2001;21(3):271-272. (Pubitemid 32895558)
8. Kline JA. Calcium channel antagonists. In: Ford MA, Delaney KA, Ling LL, Erickson T, eds. Clinical Toxicology. Philadelphia, PA: WB Saunders Company; 2001:370-378.
9. Buckley N, Dawson AH, Howarth D, et al. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust. 1993;158(3):202-204. (Pubitemid 23094591)
10. POISINDEX® System[database online]. In: Thomson Healthcare, Greenwood Village, Colorado 2008.
11. Patel NP, Pugh ME, Goldberg S, et al. Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review. Am J Crit Care. 2007;16(5):498-503.
12. Ranniger C, Roche C. Are one or two dangerous? Calcium channel blocker exposure in toddlers. J Emerg Med. 2007;33(2):145-154. (Pubitemid 47199024)
13. Belson MG, Gorman SE, Sullivan K, et al. Calcium channel blocker ingestions in children. Am J Emerg Med. 2000;18(5):581-586. (Pubitemid 30693870)
14. Punukollu G, Gowda RM, Khan IA, et al. Delayed presentation of calcium channel antagonist overdose. Am J Ther. 2003;10(2):132-134.
15. Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest. 2001;119(4):1280-1282.
16. Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071-2075. (Pubitemid 47326443)
17. Lheureux PE, Zahir S, Gris M, et al. Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care (London, England). 2006;10(3):212. (Pubitemid 47086871)
18. Cantrell FL, Clark RF, Manoguerra AS. Determining triage guidelines for unintentional overdoses with calcium channel antagonists. Clin Toxicol (Phila). 2005;43(7):849-853.
19. Lapatto-Reiniluoto O, Kivisto KT, Neuvonen PJ. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs. Clin Pharmacol Ther. 2001;70(3):255-260. (Pubitemid 32868489)
20. Hendren WG, Schieber RS, Garrettson LK. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med. 1989;18(9):984-987.
21. Kuhlmann U, Schoenemann H, Muller TF, et al. Plasmapheresis in fatal overdose with verapamil. Intensive Care Med. 1999;25(12):1473.
22. Wells CD, Luckritz TC, Rady MY, et al. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. Pharmacotherapy. 2006;26(12):1802-1805.
23. Kolcz J, Pietrzyk J, Januszewska K, et al. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med. 2007;22(6):381-385. (Pubitemid 350132178)
24. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol. 2003;41(5):595-602. (Pubitemid 37102385)
25. Papadopoulos J, O'Neil MG. Utilization of a glucagon infusion in the management of a massive nifedipine overdose. J Emerg Med. 2000;18(4):453-455. (Pubitemid 30236412)
26. Davis SN. Goodman & Gilman's The Pharmacological Basis of Therapeutics - 11th Ed. (2006) In: Brunton LL, ed. Chapter 60 Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas: McGraw-Hill, Medical Publishing Division. 2006.
27. Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care. 2002;18(1):36-37. (Pubitemid 34174344)
28. Krohn K, Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care. 2006;9(3):319-323.
29. Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41(11):1873-1877.
30. Warren JA, Thoma RB, Georgescu A, et al. Intravenous lipid infusion in the successful resuscitation of local anesthetic-induced cardiovascular collapse after supraclavicular brachial plexus block. Anesth Analg. 2008;106(5):1578- 1580, table of contents. (Pubitemid 351571097)
31. Ludot H, Tharin J-, Belouadah M, et al. Successful resuscitation after ropivacaine and lidocaine-induced ventricular arrhythmia following posterior lumbar plexus block in a child. Anesth Analg. 2008;106(5):1572-1574. (Pubitemid 351571095)
32. Weinberg G, Ripper R, Feinstein DL, et al. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28(3):198-202. (Pubitemid 36618312)
33. Weinberg GL. Lipid infusion therapy: translation to clinical practice. Anesth Analg. 2008;106(5):1340-1342.
34. Litz RJ, Popp M, Stehr SN, et al. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia. 2006;61(8):800-801. (Pubitemid 44027411)
35. Tebbutt S, Harvey M, Nicholson T, et al. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med. 2006;13(2):134-139. (Pubitemid 43155818)
36. Bania TC, Chu J, Perez E, et al. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med. 2007;14(2):105-111. (Pubitemid 46157192)
37. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89(14):6452- 6456.
38. Weinberg G. Lipid rescue: caveats and recommendations for the "Silver Bullet". Reg Anesth Pain Med. 2004;29(1):74-75.
39. Brull SJ. Lipid emulsion for the treatment of local anesthetic toxicity: patient safety implications. Anesth Analg. 2008;106(5):1337-1339.
40. Rosansky SJ. Verapamil toxicity - treatment with hemoperfusion. Ann Intern Med. 1991;114(4):340-341.
41. ter Wee PM, Kremer Hovinga TK, Uges DR, et al. 4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication. Hum Toxicol. 1985;4(3):327-329.
42. Anthony T, Jastremski M, Elliott W, et al. Charcoal hemoperfusion for the treatment of a combined diltiazem and metoprolol overdose. Ann Emerg Med. 1986;15(11):1344-1348. (Pubitemid 17184496)
43. Schiffl H, Ziupa J, Schollmeyer P. Clinical features and management of nifedipine overdosage in a patient with renal insufficiency. J Toxicol. 1984;22(4):387-395. (Pubitemid 15139157)
44. Williamson KM, Dunham GD. Plasma concentrations of diltiazem and desacetyldiltiazem in an overdose situation. Ann Pharmacother. 1996;30(6):608-611. (Pubitemid 26181702)
45. Kuhlmann U, Schoenemann H, Muller T, et al. Plasmapheresis in life-threatening verapamil intoxication. Artif Cells Blood Substit Immobil Biotechnol. 2000;28(5):429-440.
46. Holzer M, Sterz F, Schoerkhuber W, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med. 1999;27(12):2818-2823. (Pubitemid 30027203)
47. Isbister GK. Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium. Emerg Med J. 2002;19(4):355-357.
48. Melanson P, Shih RD, DeRoos F, et al. Intra-aortic balloon counterpulsation in calcium channel blocker overdose. (abstract 115). Vet Hum Toxicol. 1993;35(4):345.
49. Rodgers GC, Al-Mahasneh QM, White SL. Treatment of severe sustained release verapamil (SRV) poisoning with cardiac pacing. A case report (Abstract 190). Vet Hum Toxicol. 1989;31(4):377.
50. Satchithananda DK, Stone DL, Chauhan A, et al. Lesson of the week: unrecognised accidental overdose with diltiazem. BMJ. 2000;321(7254):160-161.
51. Tanen DA, Ruha AM, Curry SC, et al. Hypertonic sodium bicarbonate is effective in the acute management of verapamil toxicity in a swine model. Ann Emerg Med. 2000;36(6):547-553.
52. Wood DM, Wright KD, Jones AL, et al. Metaraminol (Aramine) in the management of a significant amlodipine overdose. Hum Exp Toxicol. 2005;24(7):377-381.
53. Leone M, Charvet A, Delmas A, et al. Terlipressin: a new therapeutic for calcium-channel blockers overdose. J Crit Care. 2005;20(1):114-115. (Pubitemid 40602233)
54. Meyer S, Gortner L, McGuire W, et al. Vasopressin in catecholamine- refractory shock in children. Anaesthesia. 2008;63(3):228-234.
55. Lexi-Drugs International Online[database online]. Lexi-Comp, Inc, Hudson, Ohio; 2008.